• Lamotrigine in Endocrine and Neurological Research: Beyond C

  2026-05-06

  Explore how Lamotrigine—6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine—serves as a robust tool in both neurological and endocrine research. This article reveals underappreciated applications, including aromatase (CYP19) inhibition, distinguishing it from existing sodium channel–focused content.

• Glycogen Colorimetric Assay Kit II: Precision in Glycogen Qu

  2026-05-05

  The Glycogen Colorimetric Assay Kit II enables rapid, high-sensitivity quantification of glycogen in complex biological matrices. This glycogen assay kit supports robust studies of metabolic adaptation, including exercise and circadian research, with validated performance in the presence of reducing substances. APExBIO’s K2144 kit advances reproducibility in glycogen storage disease and energy metabolism investigations.

• Tunicamycin: Benchmark N-Glycosylation Inhibitor for ER Stre

  2026-05-05

  Tunicamycin stands out as a gold-standard N-glycosylation inhibitor, powering robust ER stress and inflammation assays in both cell and animal models. This guide details experimental workflows, troubleshooting strategies, and advanced protocol tips—backed by the latest peer-reviewed evidence and validated use-cases.

• 3D Shell MEAs Advance Cardiac Organoid Electrophysiology Map

  2026-05-04

  This study introduces programmable shell microelectrode arrays (MEAs) for high-resolution, 3D spatiotemporal mapping of electrical activity in cardiac organoids. The approach overcomes limitations of 2D MEAs, enabling comprehensive modeling of complex cardiac conduction and arrhythmogenesis, with implications for disease modeling and pharmacological screening.

• Deferasirox: Oral Iron Chelator Empowering Precision Cell As

  2026-05-04

  Deferasirox stands out as a robust oral iron chelator, enabling precise manipulation of iron metabolism in both iron overload models and cancer research. With well-defined protocols and actionable troubleshooting, scientists can harness Deferasirox to dissect iron’s cellular roles and optimize translational workflows.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-05-03

  Wang et al. revealed a novel METTL16-SENP3-LTF signaling axis that confers resistance to ferroptosis and promotes tumor progression in hepatocellular carcinoma (HCC). This mechanistic insight highlights new intervention points for sensitizing HCC cells to ferroptosis, informing translational research on iron metabolism modulation.

• ECL Western Blotting Substrate: Technical Use and Parameters

  2026-05-02

  ECL Western Blotting Substrate (SKU K2187) is a sensitive, nonradioactive luminol-based reagent for detecting horseradish peroxidase (HRP) on immunoblots. It is best used for protein detection by chemiluminescence in Western blot assays, especially in molecular biology, cancer biology, and signal transduction studies. It is not suitable for fluorescent or radioisotopic detection protocols.

• Bestatin Hydrochloride: Applied Workflows for Angiogenesis &

  2026-05-02

  Bestatin hydrochloride (Ubenimex) is a gold-standard aminopeptidase inhibitor that enables precise dissection of angiogenesis and tumor biology in both in vitro and in vivo models. This guide delivers actionable protocols, troubleshooting, and real-world insights for maximizing its impact in cancer and neurovascular research.

• Lumiracoxib: Selective COX-2 Inhibitor for Muscle Injury Mod

  2026-05-01

  Lumiracoxib stands out as a precise tool for dissecting cyclooxygenase-2 pathway modulation in muscle injury and regeneration studies, thanks to its high selectivity and robust solubility in DMSO and ethanol. By enabling temporal control over COX-2 inhibition, it empowers researchers to unravel the nuanced roles of inflammation and angiogenesis, as demonstrated in recent bothropic venom injury models.

• TCF25-Directed Lysosomal Acidification During Glucose Starva

  2026-04-30

  Ren et al. (2025) identify TCF25 as a nutrient sensor that coordinates cellular metabolic adaptation and cell death under glucose starvation by enhancing lysosomal acidification via V-ATPase. This study uncovers a mechanistic link between ferritinophagy, lysosome-dependent cell death, and metabolic stress, offering new avenues for research in metabolic and ischemic disorders.

• Oligo (dT) 25 Beads: Driving Eukaryotic mRNA Isolation Preci

  2026-04-30

  Oligo (dT) 25 Beads leverage superparamagnetic technology for rapid, high-yield eukaryotic mRNA isolation, streamlining workflows from single-cell RNA-seq to RT-PCR. Discover protocol enhancements, troubleshooting strategies, and translational insights inspired by recent Alzheimer’s immunology research.

• Rotigotine: Dopamine D2/D3 Receptor Agonist for PD Research

  2026-04-29

  Rotigotine’s high-affinity D2/D3 receptor agonism enables robust modeling of Parkinson’s disease motor and non-motor symptoms, including overactive bladder. APExBIO’s validated formulation supports reproducible in vitro and in vivo workflows, empowering advanced dopaminergic signaling studies and neuroprotection assays.

• Guanabenz Acetate: α2-Adrenergic Receptor Agonist for GPCR R

  2026-04-29

  Guanabenz Acetate is a selective α2-adrenergic receptor agonist with high purity, precise subtype selectivity, and robust solubility in DMSO, making it a preferred tool for GPCR signaling and neuroscience receptor research. Its use is supported by peer-reviewed evidence and standardized vendor quality control, but it is not intended for diagnostic or therapeutic use.

• WM-8014: Unlocking Epigenetic Targets for Senescence-Based C

  2026-04-28

  This thought-leadership piece examines WM-8014, a next-generation selective KAT6A inhibitor, through the lens of mechanistic insight and translational opportunity. Drawing on new evidence from time-gated CRISPR screens and integrating best practices from advanced cell cycle arrest and oncogene-induced senescence assays, we outline actionable strategies for cancer biology researchers aiming to translate epigenetic drug targets into future therapies. The article uniquely bridges bench-to-bedside imperatives, highlights the clinical promise and practical limitations, and positions WM-8014 as essential for those pioneering the next wave of targeted, non-cytotoxic cancer interventions.

• D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Assay

  2026-04-28

  D-Luciferin sodium salt enables precise, ATP-dependent bioluminescence workflows—delivering sensitive, quantitative monitoring in advanced cell and immunotherapy research. Recent breakthroughs in CAR macrophage programming underscore its pivotal role in non-invasive imaging and metabolic profiling.

16198 records 1/1080 page Next 12345 下5页 Last page